Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Clinical Trials
481 Articles Available
1
21
Can't find what you're looking for? Try our
advanced search
.
Phase III
Soligenix Announces Phase 3 FLASH Study Continues to Demonstrate Positive Benefits in Patients with Cutaneous T-Cell Lymphoma
PR-M10-20-14
Lilly Statement on the NIAID Decision to Pause Enrollment in ACTIV-3 Clinical Trial
PR-M10-20-09
COVID-19 Long-Acting AntiBody (LAAB) Combination AZD7442 Rapidly Advances into Phase III Clinical Trials
PR-M10-20-07
Decentralized Trials
Protecting Clinical Research and Patients Through Decentralized Trial Strategies
PAP-Q3-20-CL-025
Feature Story
The COVID-19 Pandemic Magnifies Pharmaceutical Supply Chain Issues
PAP-Q3-20-NI-002
The Future of Healthcare
How Is Sanaclis Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-010
The Future of Healthcare
How Is Globyz Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-001
The Future of Healthcare
How Is Yourway Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-012
Vaccine
Merck Announces Positive Topline Results from Two Phase 3 Adult Studies Evaluating Pneumococcal Conjugate Vaccine
Clinical Trials
Hackensack Meridian Health Enrolling Individuals for COVID-19 Vaccine Clinical Trial
PR-M08-20-NI-50
Clinical Trials
AstraZeneca Initiates Phase I Clinical Trial Initiated for Monoclonal Antibody Combination for COVID-19
PR-M08-20-NI-38
COVID-19 Vaccine Funding
Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program for COVID-19 Vaccine
PR-M07-20-NI-40
COVID-19 Vaccine
Moderna Begins Phase 3 COVE Study of mRNA Vaccine Against COVID-19
PR-M07-20-NI-39
COVID-19 Approval
BioAegis Therapeutics Receives Approval to Proceed with Phase 2 Trial of its Gelsolin COVID-19 Treatment
PR-M07-20-NI-34
Positive Data
Synairgen Announces Positive Results from Trial of SNG001 in Hospitalized COVID-19 Patients
PR-M07-20-NI-31
COVID-19 Vaccine
Pfizer and BioNTech Report T Cell Response in COVID-19 Vaccine
PR-M07-20-NI-30
Clinical Trials
New Data from Phase IIIb Study Reinforces Safety Profile of Roche’s Hemlibra in People with Haemophilia A
PR-M07-20-NI-020
Funding
Genome Medical Raises $14 Million to Expand Virtual Clinical Genetics Care and Accelerate Telemedicine Technology Development
PR-M07-20-NI-017
COVID-19 Trial Data
Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of COVID-19
PR-M07-20-NI-015
Clinical Trials
Haima Therapeutics Receives Phase II TVSF Award from the State of Ohio to Develop its SynthoPlate Product for Veterinary Use
PR-M07-20-NI-014
COVID-19 Vaccine
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
PR-M06-20-NI-042
Research Innovation
Leveraging Innovative Technologies to Access Better Data More Efficiently and Cost-Effectively
PAP-Q2-20-CL-010
The Future of Healthcare
How is SanaClis Innovating through the Pandemic and Beyond to Define the Future of Healthcare?
PAP-Q2-20-RT2-011
Comparator Sourcing
Evolving Needs for Comprehensive Clinical Comparator Sourcing Strategies
PAP-Q2-20-CL-028
1
21
»
